Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.
Data will appear here once earnings are reported.

OTCQXZCOR
All numbers in thousands USD
Period Ending
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Net Income
(95,454)
(69,359)
(90,632)
(57,933)
Operating Activities, Cash Flows Provided By or Used In
Depreciation
4,193
5,062
4,118
3,014
Changes In Accounts Receivables
(4,254)
(2,793)
(728)
124
Changes In Assets and Liabilities
(217)
3,936
1,711
7,006
Changes In Inventories
429
(1,525)
137
1,571
Changes In Other Operating Activities
40,489
(485)
12,527
7,312
Total Cash Flow From Operating Activities
(54,814)
(65,164)
(72,867)
(38,906)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures
(9)
(88)
(7,237)
(18,547)
Investments
55,218
(17,496)
56,102
(100,017)
Other Cash flows from Investing Activities
0
(400)
0
(1,223)
Total Cash Flows From Investing Activities
55,209
(17,984)
48,865
(119,787)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid
--
--
--
--
Sale/Purchase of Stock
5,228
32,888
272
80,896
Net Borrowings
(1,316)
36,465
21,375
71,397
Other Cash Flows from Financing Activities
0
0
0
0
Total Cash Flows From Financing Activities
3,912
69,353
21,647
152,293
Effect Of Exchange Rate Changes
(74)
530
45
327
Change In Cash and Cash Equivalents
4,307
(13,795)
(2,355)
(6,400)

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2019 Zyla Life Sciences
All rights reserved.